Texas is intervening in the litigation as a plaintiff with the Health Choice Alliance, a research organization jointly represented by The Lanier Law Firm and McKool Smith PC.

The price hike is not expected to affect access for patients who receive Mounjaro through the National Health Service (NHS).

Mounjaro is the brand name for a drug called tirzepatide, which is a glucagon-like peptide-1 (GLP-1) that helps to lower ...

Attorney General Ken Paxton filed a lawsuit this week against Eli Lilly for allegedly bribing Texas health care providers to ...

From geopolitics to climate, tech to social change, News18 World live blog delivers real-time updates on what is the latest ...

More than 1 in 4 adults with diabetes used one of the injectable medicines that target the GLP-1 protein last year, the ...

Trump this month sent letters to the world’s largest drugmakers, including Lilly, insisting they lower what they charge ...